Inhibitors of NF-κB signaling: 785 and counting

TD Gilmore, M Herscovitch - Oncogene, 2006 - nature.com
Nuclear factor kappa B (NF-κB) transcription factors regulate several important physiological
processes, including inflammation and immune responses, cell growth, apoptosis, and the …

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment

C Steidl, JM Connors, RD Gascoyne - Journal of Clinical Oncology, 2011 - ascopubs.org
Hodgkin's lymphoma (HL) represents the most common subtype of malignant lymphoma in
young people in the Western world. Most patients can be cured with modern treatment …

Nuclear factor-κB inhibitors as sensitizers to anticancer drugs

C Nakanishi, M Toi - Nature Reviews Cancer, 2005 - nature.com
The cytotoxicity of chemotherapeutic agents is attributed to apoptosis. Acquired resistance to
the effects of chemotherapy has emerged as a significant impediment to effective cancer …

Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells

ST Nawrocki, JS Carew, K Dunner Jr, LH Boise… - Cancer …, 2005 - aacrjournals.org
Bortezomib (Velcade, formerly known as PS-341) is a boronic acid dipeptide derivative that
is a selective and potent inhibitor of the proteasome. We hypothesized that proteasome …

Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells

ST Nawrocki, JS Carew, MS Pino, RA Highshaw… - Cancer …, 2006 - aacrjournals.org
The proteasome inhibitor bortezomib (formerly known as PS-341) recently received Food
and Drug Administration approval for the treatment of multiple myeloma, and its activity is …

Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma

P Bonvini, E Zorzi, G Basso, A Rosolen - Leukemia, 2007 - nature.com
The 26S proteasome has a direct impact on cellular transcription regulation, cell-cycle
progression, oncogenesis and apoptosis, since the turnover of the vast majority of …

Characterization of curcuemulsomes: Nanoformulation for enhanced solubility anddelivery of curcumin

MH Ucisik, S Küpcü, B Schuster, UB Sleytr - Journal of nanobiotechnology, 2013 - Springer
Background Curcumin is a polyphenolic compound isolated from the rhizomes of the
plantCurcuma longa and shows intrinsic anti-cancer properties. Its medical useremains …

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications

Y Fernández, M Verhaegen, TP Miller, JL Rush… - Cancer …, 2005 - aacrjournals.org
Melanoma is the most aggressive form of skin cancer and advanced stages are invariably
resistant to conventional therapeutic agents. Using bortezomib as a prototypic proteasome …

[HTML][HTML] NFkB pathway and Hodgkin lymphoma

F Jardin - Biomedicines, 2022 - mdpi.com
The tumor cells that drive classical Hodgkin lymphoma (cHL), namely, Hodgkin and Reed-
Sternberg (HRS) cells, display hallmark features that include their rareness in contrast with …

Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance

D Aldinucci, M Celegato, N Casagrande - Cancer letters, 2016 - Elsevier
Classical Hodgkin lymphoma (cHL) is characterized by few tumor cells surrounded by
immune cells, fibroblasts, specialized mesenchymal stromal cells and endothelial cells …